Brief: GRAIL Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational Study
18/06/2025 14:24
June 18 (Reuters) - Grail Inc GRAL.O: GRAIL ANNOUNCES POSITIVE TOP-LINE RESULTS FROM THE GALLERI® PATHFINDER 2 REGISTRATIONAL STUDY GRAIL INC - EXPECTS TO COMPLETE PMA MODULAR SUBMISSION IN FIRST HALF OF 2026 GRAIL INC - NO SERIOUS SAFETY CONCERNS REPORTED IN PATHFINDER 2 Source text: ID:nPn789Tc7a Further company coverage: GRAL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grail
See all newsGrail rises as TD Cowen more than doubles PT on FDA, Medicare optimism
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
U.S. RESEARCH ROUNDUP-Chevron, Mobility Global, Tesla
Street View: Grail cancer test's progress boosts prospects for multi-cancer detection market
NASDAQ RESUMED AT 07:05 AM